The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
University of Florida · NCT00500123
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 50000
- US sites recruiting
- 1
- Study start
- January 2001
- Record last updated
- November 24, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.
Being studied: Alpha-1 Antitrypsin Genotype
Conditions: Alpha-1 Antitrypsin Deficiency
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Individuals of any age at risk for alpha-1 antitrypsin deficiency on the basis of symptoms or family genetic risk.
Exclusion Criteria
- Any person who has already had genotype and AAT level testing completed and has a qualified result.
Recruiting US locations
University of Florida
Gainesville, FL 32610
Site contact: Michelle Owens, RN, BSN · 352-273-6339 · Sandra.Owens@medicine.ufl.edu
Study contacts (from the official record)
- Michelle Owens, RN, BSN · 352-273-6339 · Sandra.Owens@medicine.ufl.edu
- Allison Faunce, B.A. · 352-273-8666 · Allison.Faunce@medicine.ufl.edu
Similar studies in Florida
All healthy volunteers studies in Florida →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4302814 in Healthy Participants
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Orlando, FL + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
BioCorRx Pharmaceuticals Inc
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Miami, FL + 6 other US sites
- Eligibility basics
- Ages 18–65